Anand Mehra - 19 Nov 2024 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
Director
Signature
/s/ Matthew Rothman, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
19 Nov 2024
Net transactions value
+$1,499,998
Form type
4
Filing time
20 Nov 2024, 16:20:04 UTC
Previous filing
10 Jun 2024
Next filing
27 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Purchase $1,499,998 +666,666 +1537% $2.25 710,030 19 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock of the Issuer acquired from the Issuer pursuant to Rule 16b-3(d).